Tracheo-parenchymal fistula following concurrent chemo-radiation for stage III NSCLC

被引：4

作者：

Alzghoul, Bashar ^{[1
]}

Meena, Nikhil ^{[1
,2
]}

机构：

[1] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA

[2] Univ Arkansas Med Sci, Div Pulm & Crit Care Med, Little Rock, AR 72205 USA

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2016年 / 18卷

关键词：

Bronchoscopy; Lung cancer; Chemo-radiation; Tracheo-pulmonary fistula;

D O I：

10.1016/j.rmcr.2016.03.007

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Non-Small Cell Cancer (NSCLC) are frequently diagnosed at a later stage [1]. Treatment involves chemotherapy and radiation, either sequentially or concurrently [2]. Concurrent therapy is more efficacious but also associated with more complications [4-6]. We present a rare care of trachea-pulmonary fistula formation after concurrent chemo and radiation in a patient with Squamous Cell Cancer (SCC). (C) 2016 The Authors. Published by Elsevier Ltd.

引用

页码：22 / 23

页数：2

共 50 条

[31] Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer
Rodrigues, George
TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (02) : 195 - 197
[32] PHASE I/II TRIAL OF RECOMBINANT HUMAN ENDOSTATIN IN COMBINATION WITH CONCURRENT CHEMO-RADIOTHERAPY IN THE PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER
Chen, Ming
Bao, Yong
Peng, Fang
Zhou, Qi C.
Yu, Zhong Hua
Li, Jian Cheng
Cheng, Zhi Bin
Chen, Long
Hu, Xiao
Chen, Yuan Y.
Wang, Jin
Ma, Hong Lian
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S410 - S411
[33] New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group
Catania, Chiara
Filippi, Andrea Riccardo
Sangalli, Claudia
Piperno, Gaia
Russano, Marco
Greco, Carlo
Scotti, Vieri
Proto, Claudia
Bennati, Chiara
Paolo, Marzia Di Pietro
Platania, Angelo
Olmetto, Emanuela
Agustoni, Francesco
Teodorani, Nazario
Agbaje, Vincenzo
Russo, Alessandro
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 190
[34] Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
Dang, Jun
Li, Guang
Zang, Shuang
Zhang, Shuo
Yao, Lei
RADIATION ONCOLOGY, 2014, 9
[35] Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer
Kalemkerian, GP
Belzer, K
Wozniak, AJ
Gaspar, LE
Valdivieso, M
Kraut, MJ
LUNG CANCER, 1999, 25 (03) : 175 - 182
[36] Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database
Yacouba, Mohamed Bassirou Moukeila
Feng, Maohui
Thokerunga, Erick
Bongolo, Christian Cedric
Gado, Adamou Foumakoye
He, Feng
Ke, Jianjuan
Zhang, Zongze
Wang, Yanlin
MEDICINE, 2023, 102 (19) : E33760
[37] Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial? In Regard to Rodrigues et al
Cobben, D. C. P.
Jager, P. L.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (03): : 699 - 700
[38] PHASE II TRIAL OF HYPERFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY AND CONCURRENT WEEKLY CISPLATIN FOR STAGE III AND IVa HEAD-AND-NECK CANCER
Maguire, Patrick D.
Papagikos, Michael
Hamann, Sue
Neal, Charles
Meyerson, Martin
Hayes, Neil
Ungaro, Peter
Kotz, Kenneth
Couch, Marion
Pollock, Hoke
Tepper, Joel
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1081 - 1088
[39] Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
Jin, Jian-Yue
Hu, Chen
Xiao, Ying
Zhang, Hong
Paulus, Rebecca
Ellsworth, Susannah G.
Schild, Steven E.
Bogart, Jeffrey A.
Dobelbower, Michael Chris
Kavadi, Vivek S.
Narayan, Samir
Iyengar, Puneeth
Robinson, Cliff
Greenberger, Joel S.
Koprowski, Christopher
Machtay, Mitchell
Curran, Walter
Choy, Hak
Bradley, Jeffrey D.
Kong, Feng-Ming
CANCERS, 2021, 13 (24)
[40] Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
Benedikt Flörsch
Julian Taugner
Lukas Käsmann
Saskia Kenndoff
Julian Guggenberger
Amanda Tufman
Niels Reinmuth
Thomas Duell
Claus Belka
Chukwuka Eze
Farkhad Manapov
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3267 - 3276

← 1 2 3 4 5 →